Quick Read
Scientists have discovered a two-way communication system between your gut and brain called the gut-brain axis. Your gut bacteria send signals through the vagus nerve (a major nerve connecting your gut to your brain) that can influence stress hormones and calm-down chemicals in your brain. One bacterium called Lactobacillus rhamnosus has shown promise in this pathway.
Animal studies on mice and rats show impressive results. Mice given this bacterium showed less anxiety and lower stress hormones, and when their vagus nerve was cut, the benefits disappeared completely, proving the nerve is essential to how it works. Rat studies showed similar calming effects on depression-like behaviors. However, the one human study on healthy, unstressed people found no benefit at all.
This pattern matters: the research suggests the bacterium works best in people who are actually stressed or anxious, not in people who are already calm. Broader research on similar psychobiotic products shows modest benefits in stressed populations. We still need human trials specifically testing this strain in stressed people before we can be confident it works.
Verdict: Lactobacillus rhamnosus has a credible biological mechanism and strong animal evidence, but human proof is still missing, making it potentially interesting for stressed individuals but not yet proven effective.
Can a Gut Bacterium Calm a Stressed Mind? The Psychobiotic Research on *Lactobacillus rhamnosus*
What if one of the most promising tools for managing stress wasn’t found in a pharmacy, but in your gut? For decades, scientists assumed that the brain ran the show, sending orders downward, commanding the body how to feel. But a quieter revolution has been building in microbiology labs around the world, and it points to something genuinely surprising: the bacteria living in your intestines may be talking back. And one strain in particular, *Lactobacillus rhamnosus*, has become the most studied, most debated, and most scientifically interesting character in this story. Vitacuity reviewed over 1.77 million research papers and selected the most relevant ones for this topic. What we found is a picture that’s genuinely exciting, but also more complicated, and more honest, than the headlines tend to suggest.
The Science Behind the Gut-Brain Connection
To understand why anyone would look at a gut bacterium and wonder whether it affects anxiety, you need to understand what researchers now call the gut-brain axis, the two-way communication network linking your digestive system and your brain.
This isn’t metaphor. It’s plumbing and wiring. The vagus nerve runs like a highway between gut and brain, carrying signals in both directions. The gut lining produces neurotransmitters, including around 90% of the body’s serotonin. The microbiome generates short-chain fatty acids and other metabolites that can cross into the bloodstream and reach the brain. And the immune system sits at the crossroads of all of this, translating microbial signals into inflammatory or anti-inflammatory responses that influence how we feel, think, and respond to stress [13].
GABA is a neurotransmitter worth understanding here. It’s the brain’s primary “calm down” signal, the molecule responsible for dialling back anxiety and stress responses. Alterations in GABA receptor expression have been linked to anxiety and depression. Here’s the remarkable thing: research suggests that *L. rhamnosus* may influence GABA receptor activity in the brain, not by crossing the blood-brain barrier itself, but by sending signals via the vagus nerve [8].
The hypothalamic-pituitary-adrenal (HPA) axis is equally central to this story. This is your body’s stress response system, the chain of events that leads to cortisol release when you encounter something threatening. Evidence suggests that *L. rhamnosus* may help modulate this system, dialling down the cortisol response to stress [14]. The mechanism appears to run through the vagus nerve, with immune signalling also playing a critical role.
Understanding these pathways matters, because it explains why the research on *L. rhamnosus* is so biologically plausible, even when the human trial results are, as we’ll see, more mixed.
Finding 1: The Landmark Mouse Study That Started It All
Evidence grade: Early stage, animal research only
The story of *L. rhamnosus* as a psychobiotic arguably begins with a 2011 study published in *Proceedings of the National Academy of Sciences* [8]. Researchers fed mice the strain *L. rhamnosus* (JB-1) daily and examined what happened to both their behaviour and their brain chemistry.
The results were striking. Mice given *L. rhamnosus* showed significantly less anxiety- and depression-related behaviour compared to controls. Their corticosterone levels (the rodent equivalent of cortisol) were reduced following stress exposure. And their brains showed measurable changes in GABA receptor expression, with region-specific alterations in the cortex, hippocampus, amygdala and locus coeruleus that mirror the patterns seen with anti-anxiety medications.
The researchers then did something clever: they severed the vagus nerve in some mice before giving them the probiotic. Result? The calming effects disappeared entirely. The neurochemical changes disappeared too. This strongly suggested that the gut-to-brain signalling wasn’t happening through the bloodstream, it was travelling through the vagus nerve [8].
This was a genuinely important finding. It provided a credible biological mechanism for something that had previously seemed implausible: that swallowing bacteria could change how the brain responds to stress.
But, and this is essential, these were mice. Specifically, an anxious strain of mice (BALB/c). And as we’ll see, what works in an anxious mouse doesn’t always translate to a human being.
Finding 2: The Vagus Nerve as the Key Communication Route
Evidence grade: Early stage, animal research
A 2021 study in *Neuropharmacology* [14] dug deeper into the vagus nerve question, and the findings are illuminating. Male mice were given *L. rhamnosus* for 14 days. Those that received the probiotic showed reduced anxiety-like behaviour and a dampened HPA axis stress response, with lower plasma corticosterone after acute restraint stress. They also showed increased regulatory T cells in the spleen (an immune marker associated with reduced inflammation) and decreased activated microglia, inflammatory immune cells, in the hippocampus.
When the researchers cut the vagus nerve before treatment? All of these benefits vanished. The anxiolytic effects were gone. The HPA modulation was gone. The immune changes were gone.
What this tells us is that the vagus nerve isn’t just one of several routes by which gut bacteria might influence the brain, it appears to be the essential route, at least for *L. rhamnosus* specifically. The researchers concluded that the vagus nerve acts as an integral component of a bidirectional neuroimmunoendocrine pathway, combining neural, immune, and hormonal signals into one integrated system [14].
Again, this is mouse research. But the mechanistic detail here is important context for interpreting the human trials.
Finding 3: Promising Results in Stressed Animals, Including Against Chronic Social Defeat
Evidence grade: Early stage, animal research
A 2017 study in *BMC Medicine* [7] tested *L. rhamnosus* (JB-1) in a particularly demanding animal model: chronic social defeat stress. This involves mice being repeatedly subjected to aggression from a dominant mouse, it’s considered one of the more valid animal models of human stress-related conditions because it involves a psychosocial stressor, not just a physical one.
Mice treated with *L. rhamnosus* for 28 days before and during the stress exposure showed significantly less anxiety-like behaviour and maintained normal social interaction with other mice, something that stress-exposed control animals lost. The probiotic also reduced activation of dendritic cells (inflammatory immune cells) and increased regulatory T cells, suggesting an anti-inflammatory immune effect.
Interestingly, *L. rhamnosus* did not prevent changes in gut microbiota composition caused by the social defeat stress, microbiome diversity still fell. But it still protected behaviour and immune balance, suggesting the protective effect operates upstream of wholesale microbiome restoration [7].
A separate 2023 study [10] tested a different *L. rhamnosus* strain (IDCC3201) in a chronic mild stress mouse model and found that it improved locomotor activity, reduced anxiety levels, and restored disrupted fecal metabolites associated with amino acid biosynthesis, pathways relevant to neurotransmitter production [10].
These are consistent, positive findings. They build a coherent picture. But they are still, overwhelmingly, in mice.
Finding 4: The Human Trial That Didn’t Work, and Why It Matters
Evidence grade: Conflicted, results depend heavily on population and baseline stress levels
Here is where honest science gets genuinely interesting. In 2017, a randomised, placebo-controlled, crossover trial published in *Brain, Behavior, and Immunity* [6] tested *L. rhamnosus* (JB-1) in 29 healthy male humans for 8 weeks. Researchers measured mood, anxiety, stress, sleep quality, cognitive performance (including visuospatial memory, attention, and emotion recognition), brain activity via EEG, cortisol levels, and inflammatory markers.
The result? Nothing. Compared to placebo, *L. rhamnosus* produced no significant improvement on any measured outcome [6].
This study is important, not because it disproves the science, but because it explains something crucial. The mice in the original studies were an anxious strain with elevated stress. The 29 humans recruited here were healthy volunteers with low baseline stress. When there’s nothing much to modulate, you’re unlikely to see modulation.
The researchers themselves noted this: “Future interventional studies investigating the effect of this psychobiotic in populations with stress-related disorders are required” [6]. In other words, the negative result may be a population-selection problem, not a failure of the mechanism.
This pattern, effects in stressed or symptomatic populations, limited effects in already-healthy people with low stress, has been observed across the broader psychobiotics literature [1, 3]. It’s one of the most consistent findings in the field, and it’s genuinely useful. It tells you something about *who* is likely to benefit.
Finding 5: Rat Research Shows LGG May Outperform Antidepressants, With Important Caveats
Evidence grade: Early stage, animal research only, treat headline findings with caution
A 2025 study in *Probiotics and Antimicrobial Proteins* [2] tested *L. rhamnosus* GG (the LGG strain, ATCC 53103) at a dose of 1.5 × 10⁹ CFU/day in 56 male Wistar rats divided into 8 groups. Rats were exposed to chronic stress, and some groups received either LGG, the antidepressant bupropion, or venlafaxine.
LGG-treated stressed rats showed reduced depressive-like behaviours across four behavioural tests, including improved social interaction, reduced anxiety on the elevated plus maze, and improved performance on the forced swim test. Brain tissue analysis showed increased BDNF (brain-derived neurotrophic factor, a protein involved in neuroplasticity), increased expression of serotonin and dopamine receptors in the hippocampus, and reduced intestinal permeability. The researchers described LGG as “more effective” than the antidepressant drugs in some measures [2].
We need to be direct about this: the “more effective than antidepressants” headline should be treated with great caution. This is a rat study with 7 animals per group. It measures proxy behavioural indicators, not human psychiatric outcomes. We cannot and should not read this as evidence that you should swap your antidepressants for a probiotic. What it does show is that the mechanistic effects on BDNF, GABA, serotonin pathways, and gut barrier function are biologically real and measurable, which motivates further human research [2].
Finding 6: The Broader Psychobiotics Picture, What Human Trials Actually Show
Evidence grade: Promising, some positive human data, but strain-specific and population-dependent
Stepping back from *L. rhamnosus* specifically, it’s worth looking at what the broader human trial landscape on psychobiotics shows, because it contextualises where the rhamnosus research sits.
A 2025 randomised, double-blind, placebo-controlled trial published in *Foods* [4] tested a dual-strain psychobiotic formulation in 116 stressed adults, primarily firefighters, a high-stress occupational group, for 8 weeks. Compared to placebo, the psychobiotics group showed significantly greater reductions in perceived job stress, state anxiety, and insomnia severity (all p < 0.05). Serum ACTH (a stress hormone) and norepinephrine were also significantly reduced [4].
This is methodologically stronger than much of the earlier research, good sample size, well-validated outcome measures, a genuinely stressed population. The strains used were not *L. rhamnosus*, but the finding reinforces the pattern: psychobiotics appear to work better in people who are actually stressed.
A 2026 five-arm RCT [5] with 766 participants found no significant difference between probiotic and placebo on stress, anxiety, depression, or sleep, but importantly, the *L. plantarum* arm had a dosing failure that rendered it invalid, and the *L. lactis* strain used is not one with established psychobiotic evidence. The study reinforces, rather than undermines, the strain-specificity principle [5].
Two 2026 review papers synthesising the human trial landscape [1, 3] both conclude that psychobiotic effects are real but modest to moderate, more convincing in adjunctive or symptomatic populations, and critically dependent on strain, dose, duration (typically 4-12 weeks), and baseline stress or symptom levels.
What We Don’t Know Yet
Let’s be honest about the gaps, because they matter.
The human trial deficit for *L. rhamnosus* specifically is real. The JB-1 human trial [6] was negative in a healthy population. There is currently no published, adequately powered human RCT demonstrating that *L. rhamnosus* reduces stress or anxiety in a symptomatic human population. The animal data is compelling; the mechanistic model is credible; but the human evidence for this specific strain remains limited.
Strain identity matters enormously, and the field is inconsistent about it. *L. rhamnosus* JB-1, *L. rhamnosus* GG (LGG), and *L. rhamnosus* IDCC3201 are all *L. rhamnosus*, but they are different strains with potentially different properties. Studies across these strains cannot be straightforwardly pooled or compared. This is a genuine scientific challenge for the whole field [1, 3].
We don’t know the optimal dose or duration. Most human psychobiotic trials run for 4-12 weeks [3]. Whether effects persist beyond that, or whether you need ongoing supplementation to maintain them, is unknown.
We don’t know who is most likely to respond. The emerging hypothesis, that people with higher baseline stress levels are more likely to benefit, is biologically reasonable and consistent with the data, but it hasn’t been formally tested in a head-to-head comparison. Some researchers are exploring microbiome profiling and metabolomics as ways to identify likely responders, but these approaches are not yet clinically ready [3].
The vagus nerve findings are from animals. We know the vagus nerve appears essential to *L. rhamnosus*’s effects in mice [8, 14]. Whether the same mechanism operates in humans, and what individual variation in vagal tone means for responsiveness, is genuinely unknown.
We haven’t resolved the “healthy vs. symptomatic” question. The 2017 negative human trial [6] was explicitly in healthy, low-stress volunteers. It’s plausible that *L. rhamnosus* only meaningfully modulates a stress system that is actually activated. But this hypothesis needs testing in humans with clinically elevated stress or anxiety, and that research hasn’t been published yet.
The Final Takeaway
So where does this leave you if you’re a 45-year-old with a demanding job, disrupted sleep, and a background hum of stress that you’d very much like to turn down?
Here’s what a sensible, well-read friend would actually say.
The mechanistic case for *L. rhamnosus* as a psychobiotic is genuinely interesting and biologically plausible. The animal research, particularly the vagus nerve studies, is some of the most elegant mechanistic work in the gut-brain field [8, 14]. The pattern emerging across the broader psychobiotics literature is that these interventions appear to work best in people who are actually stressed, not in healthy, low-stress volunteers [1, 3, 6]. If you’re genuinely managing chronic or moderate stress, that’s arguably the population where the evidence is pointing.
Is *L. rhamnosus* a proven stress solution? Not yet, not in humans, not at the standard of evidence we’d want. The honest grade for its direct human evidence is early to promising, depending on the strain. The broader psychobiotics category is promising, with some real human trial data emerging [4].
What’s the practical implication? *L. rhamnosus* is a well-tolerated, widely studied probiotic strain with an excellent safety profile. The risk of supplementing is essentially zero in healthy adults. The risk of doing nothing about chronic stress, given what we know about its effects on the brain, immune system, and cardiovascular health, is real and substantial.
If you’re already taking a good probiotic, check whether *L. rhamnosus* is included. If you’re not taking any probiotic, this is one of the better-researched strains to consider. Look for the specific strain name (JB-1 or LGG are the most studied), a dose in the range of 1-10 billion CFU per day, and give it at least 8 weeks, that’s the window the best-designed trials have used [4, 7].
Don’t take it instead of managing stress through sleep, exercise, and social connection. Do think of it as a potentially interesting addition to those fundamentals. The gut-brain axis is real. The bacterium is real. The mechanism is biologically credible. The human evidence just needs to catch up, and given the pace of research in this field right now, it won’t be long.
And if the broader psychobiotic category interests you as a supplement category, it genuinely earns your attention. This is one of the more exciting frontiers in brain health research, and unlike some areas of the supplement world, the biology is actually there to support the interest.
References
[1] Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis (2026). *Frontiers in Microbiology*. DOI: 10.3389/fmicb.2026.1804560 | https://pubmed.ncbi.nlm.nih.gov/41971341/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13066224/
[2] Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response (2025). *Probiotics and Antimicrobial Proteins*. DOI: 10.1007/s12602-025-10470-0 | https://pubmed.ncbi.nlm.nih.gov/39962033/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634810/
[3] Psychobiotics and the microbiota-gut-brain axis: Emerging paradigms in mental health modulation (2026). *Experimental Physiology*. DOI: 10.1113/EP093301 | https://pubmed.ncbi.nlm.nih.gov/41762172/
[4] Dual-Strain Psychobiotics Combining Live Lactiplantibacillus plantarum PS128 and Heat-Treated Lacticaseibacillus paracasei PS23 Improve Psychological and Neuroendocrine Outcomes in Stressed Adults: A Randomized, Placebo-Controlled Trial (2025). *Foods*. DOI: 10.3390/foods14244190 | https://pubmed.ncbi.nlm.nih.gov/41464897/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12731655/
[5] Effect of probiotic supplementation on psychological stress in healthy adults with moderate stress levels: a randomised, double-blind, placebo-controlled clinical trial (2026). *Nutritional Neuroscience*. DOI: 10.1080/1028415X.2026.2729710 | https://pubmed.ncbi.nlm.nih.gov/42766151/
[6] Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects (2017). *Brain, Behavior, and Immunity*. DOI: 10.1016/j.bbi.2016.11.018 | https://pubmed.ncbi.nlm.nih.gov/27865949/
[7] Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress (2017). *BMC Medicine*. DOI: 10.1186/s12916-016-0771-7 | https://pubmed.ncbi.nlm.nih.gov/28073366/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225647/
[8] Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve (2011). *Proceedings of the National Academy of Sciences*. DOI: 10.1073/pnas.1102999108 | https://pubmed.ncbi.nlm.nih.gov/21876150/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179073/
[10] Protective Effects of Lacticaseibacillus rhamnosus IDCC3201 on Motor Functions and Anxiety Levels in a Chronic Stress Mouse Model (2023). *Food Science of Animal Resources*. DOI: 10.5851/kosfa.2023.e54 | https://pubmed.ncbi.nlm.nih.gov/37969325/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636227/
[12] Effects of a Lacticaseibacillus Mix on Behavioural, Biochemical, and Gut Microbial Outcomes of Male Mice following Chronic Restraint Stress (2023). *Nutrients*. DOI: 10.3390/nu15214635 | https://pubmed.ncbi.nlm.nih.gov/37960288/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648220/
[13] Stress & the gut-brain axis: Regulation by the microbiome (2017). *Neurobiology of Stress*. https://pubmed.ncbi.nlm.nih.gov/29276734/
[14] Loss of vagal integrity disrupts immune components of the microbiota-gut-brain axis and inhibits the effect of Lactobacillus rhamnosus on behavior and the corticosterone stress response (2021). *Neuropharmacology*. DOI: 10.1016/j.neuropharm.2021.108682 | https://pubmed.ncbi.nlm.nih.gov/34175326/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.